
Magdalene K. Sgagias
Examiner (ID: 4537, Phone: (571)272-3305 , Office: P/1632 )
| Most Active Art Unit | 1632 |
| Art Unit(s) | 1632 |
| Total Applications | 637 |
| Issued Applications | 229 |
| Pending Applications | 42 |
| Abandoned Applications | 366 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 14959281
[patent_doc_number] => 20190307118
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-10
[patent_title] => SINGLE-STEP VITRIFICATION METHODS
[patent_app_type] => utility
[patent_app_number] => 16/470268
[patent_app_country] => US
[patent_app_date] => 2017-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10090
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16470268
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/470268 | SINGLE-STEP VITRIFICATION METHODS | Dec 14, 2017 | Abandoned |
Array
(
[id] => 13386989
[patent_doc_number] => 20180245036
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-30
[patent_title] => OOCYTES DERIVED FROM OVARIAN CULTURE INITIALLY CONTAINING NO OOCYTES
[patent_app_type] => utility
[patent_app_number] => 15/828128
[patent_app_country] => US
[patent_app_date] => 2017-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5211
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15828128
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/828128 | OOCYTES DERIVED FROM OVARIAN CULTURE INITIALLY CONTAINING NO OOCYTES | Nov 29, 2017 | Abandoned |
Array
(
[id] => 14345381
[patent_doc_number] => 20190154663
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-23
[patent_title] => METHOD AND DEVICE FOR DRUG SCREENING
[patent_app_type] => utility
[patent_app_number] => 16/071405
[patent_app_country] => US
[patent_app_date] => 2017-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3520
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16071405
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/071405 | METHOD AND DEVICE FOR DRUG SCREENING | Oct 22, 2017 | Abandoned |
Array
(
[id] => 12177495
[patent_doc_number] => 20180036431
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-08
[patent_title] => 'DELIVERY OF POLYNUCLEOTIDES USING RECOMBINANT AAV9'
[patent_app_type] => utility
[patent_app_number] => 15/717158
[patent_app_country] => US
[patent_app_date] => 2017-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 18023
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15717158
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/717158 | DELIVERY OF POLYNUCLEOTIDES USING RECOMBINANT AAV9 | Sep 26, 2017 | Abandoned |
Array
(
[id] => 12204842
[patent_doc_number] => 20180050068
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-22
[patent_title] => 'METASTATIC CANCER DECOY TRAP'
[patent_app_type] => utility
[patent_app_number] => 15/716893
[patent_app_country] => US
[patent_app_date] => 2017-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 12903
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15716893
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/716893 | METASTATIC CANCER DECOY TRAP | Sep 26, 2017 | Abandoned |
Array
(
[id] => 12240130
[patent_doc_number] => 20180072993
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-15
[patent_title] => 'METHODS FOR ENHANCING MATURATION OF CARDIOMYOCYTES'
[patent_app_type] => utility
[patent_app_number] => 15/699011
[patent_app_country] => US
[patent_app_date] => 2017-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 9598
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15699011
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/699011 | METHODS FOR ENHANCING MATURATION OF CARDIOMYOCYTES | Sep 7, 2017 | Abandoned |
Array
(
[id] => 14468351
[patent_doc_number] => 20190185818
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-20
[patent_title] => NOVEL CHICKEN EGG-BASED METASTASIS MODEL FOR CANCER
[patent_app_type] => utility
[patent_app_number] => 16/327291
[patent_app_country] => US
[patent_app_date] => 2017-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7193
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -52
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16327291
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/327291 | NOVEL CHICKEN EGG-BASED METASTASIS MODEL FOR CANCER | Aug 23, 2017 | Abandoned |
Array
(
[id] => 12206030
[patent_doc_number] => 20180051257
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-22
[patent_title] => 'METHODS FOR GENERATING ALVEOLAR TYPE II CELLS'
[patent_app_type] => utility
[patent_app_number] => 15/653489
[patent_app_country] => US
[patent_app_date] => 2017-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 4444
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15653489
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/653489 | METHODS FOR GENERATING ALVEOLAR TYPE II CELLS | Jul 17, 2017 | Abandoned |
Array
(
[id] => 12126546
[patent_doc_number] => 20180010133
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-11
[patent_title] => 'METHOD OF PRODUCING EXOSOMES FROM STEM CELLS AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/645145
[patent_app_country] => US
[patent_app_date] => 2017-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 35
[patent_no_of_words] => 11212
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15645145
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/645145 | Method of producing enriched exosomes | Jul 9, 2017 | Issued |
Array
(
[id] => 12091251
[patent_doc_number] => 20170348345
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-07
[patent_title] => 'Combination Therapy For Cancer'
[patent_app_type] => utility
[patent_app_number] => 15/644860
[patent_app_country] => US
[patent_app_date] => 2017-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 2242
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15644860
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/644860 | Combination Therapy For Cancer | Jul 9, 2017 | Abandoned |
Array
(
[id] => 14273633
[patent_doc_number] => 20190134101
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-09
[patent_title] => GENETICALLY MODIFIED HUMAN UMBILICAL CORD PERIVASCULAR CELLS FOR WOUND HEALING
[patent_app_type] => utility
[patent_app_number] => 16/309741
[patent_app_country] => US
[patent_app_date] => 2017-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19445
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -148
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16309741
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/309741 | GENETICALLY MODIFIED HUMAN UMBILICAL CORD PERIVASCULAR CELLS FOR WOUND HEALING | Jun 14, 2017 | Abandoned |
Array
(
[id] => 12980749
[patent_doc_number] => 20170342460
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-30
[patent_title] => METHOD FOR SCREENING FOR BIOACTIVE NATURAL PRODUCTS
[patent_app_type] => utility
[patent_app_number] => 15/617898
[patent_app_country] => US
[patent_app_date] => 2017-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13871
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15617898
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/617898 | METHOD FOR SCREENING FOR BIOACTIVE NATURAL PRODUCTS | Jun 7, 2017 | Abandoned |
Array
(
[id] => 16361321
[patent_doc_number] => 20200318072
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-08
[patent_title] => Process for Generation, Identification and Isolation of Human Pluripotent Stem Cell-derived Cardiomyocytes and Cardiomyocyte Subpopulations
[patent_app_type] => utility
[patent_app_number] => 16/305364
[patent_app_country] => US
[patent_app_date] => 2017-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12390
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16305364
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/305364 | Process for generation, identification and isolation of human pluripotent stem cell-derived cardiomyocytes and cardiomyocyte subpopulations | May 29, 2017 | Issued |
Array
(
[id] => 12029570
[patent_doc_number] => 20170319669
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-09
[patent_title] => 'METHOD OF ENHANCING VIRAL-MEDIATED GENE DELIVERY'
[patent_app_type] => utility
[patent_app_number] => 15/586164
[patent_app_country] => US
[patent_app_date] => 2017-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 16622
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15586164
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/586164 | METHOD OF ENHANCING VIRAL-MEDIATED GENE DELIVERY | May 2, 2017 | Abandoned |
Array
(
[id] => 17148418
[patent_doc_number] => 11141470
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-10-12
[patent_title] => B4GALNT2 knock out pig
[patent_app_type] => utility
[patent_app_number] => 15/494976
[patent_app_country] => US
[patent_app_date] => 2017-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 51
[patent_no_of_words] => 8285
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15494976
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/494976 | B4GALNT2 knock out pig | Apr 23, 2017 | Issued |
Array
(
[id] => 14310363
[patent_doc_number] => 20190144885
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-16
[patent_title] => METHODS FOR SELECTIVELY MODULATING THE ACTIVITY OF DISTINCT SUBTYPES OF CELLS
[patent_app_type] => utility
[patent_app_number] => 16/094636
[patent_app_country] => US
[patent_app_date] => 2017-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19675
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16094636
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/094636 | Nipah virus envelope glycoprotein pseudotyped lentivirus | Apr 19, 2017 | Issued |
Array
(
[id] => 14342839
[patent_doc_number] => 20190153392
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-23
[patent_title] => PROCESS FOR ISOLATING NUCLEATED CELLS AND NUCLEATED CELL POPULATIONS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/091722
[patent_app_country] => US
[patent_app_date] => 2017-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16662
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16091722
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/091722 | PROCESS FOR ISOLATING NUCLEATED CELLS AND NUCLEATED CELL POPULATIONS AND USES THEREOF | Apr 5, 2017 | Abandoned |
Array
(
[id] => 14375637
[patent_doc_number] => 20190161731
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-30
[patent_title] => DIRECT REPROGRAMMING OF SOMATIC CELLS INTO MYOGENIC CELLS
[patent_app_type] => utility
[patent_app_number] => 16/091700
[patent_app_country] => US
[patent_app_date] => 2017-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22337
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16091700
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/091700 | DIRECT REPROGRAMMING OF SOMATIC CELLS INTO MYOGENIC CELLS | Apr 5, 2017 | Abandoned |
Array
(
[id] => 11689590
[patent_doc_number] => 20170165305
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-15
[patent_title] => 'ONCOLYTIC RHABDOVIRUS'
[patent_app_type] => utility
[patent_app_number] => 15/436520
[patent_app_country] => US
[patent_app_date] => 2017-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 33977
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15436520
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/436520 | ONCOLYTIC RHABDOVIRUS | Feb 16, 2017 | Abandoned |
Array
(
[id] => 13899151
[patent_doc_number] => 20190038780
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-07
[patent_title] => VECTORS AND SYSTEM FOR MODULATING GENE EXPRESSION
[patent_app_type] => utility
[patent_app_number] => 16/075218
[patent_app_country] => US
[patent_app_date] => 2017-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7198
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16075218
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/075218 | VECTORS AND SYSTEM FOR MODULATING GENE EXPRESSION | Feb 2, 2017 | Abandoned |